EntroGen, Inc.
PrivateMomentum
Top 10%
of companies Caplight tracks
Company Overview
EntroGen, Inc. is a biotechnology company that develops and offers end-to-end solutions in molecular diagnostics for oncology and hematology by providing hardware, reagents, and software.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EntroGen, Inc. Comparables
Compare EntroGen, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pillar Biosciences | 84% | |
| Amoy Diagnostics Co., Ltd. | 79% | |
| Luye Pharma Group | 76% | |
EntroGen, Inc. Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 34% MoM, reaching 2.2K.
- Jul 20, 2026
Open roles increased to 20, 91% of headcount.
EntroGen, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EntroGen, Inc.'s valuation, stock price, and market status.